Mental health resilience in offspring of depressed parents: a systematic literature review protocol.


Journal

Systematic reviews
ISSN: 2046-4053
Titre abrégé: Syst Rev
Pays: England
ID NLM: 101580575

Informations de publication

Date de publication:
05 09 2022
Historique:
received: 06 05 2021
accepted: 23 08 2022
entrez: 5 9 2022
pubmed: 6 9 2022
medline: 9 9 2022
Statut: epublish

Résumé

Parental depression is associated with a range of mental health conditions and other difficulties in the offspring. Nevertheless, some offspring exposed to parental depression do not develop mental health problems, indicating the presence of protective factors that may buffer parental depression-related risk effects. However, evidence of protective factors that might explain good sustained mental health in offspring of depressed parents is limited and systematic synthesis of these factors is still needed. Therefore, as far as we are aware, this will be the first systematic review that will identify parent, family, child, social, and lifestyle factors associated with mental health resilience in offspring of depressed parents, examine evidence for sex-, developmental stage-, and outcome-specific factors and define mental health resilience in the parental depression context. This protocol has been developed according to the PRISMA-P guidelines. Electronic searches will be performed for articles published up to 2022 in PsycINFO, Embase, MEDLINE, Web of Science Core Collection, and Cochrane Library. Two reviewers will independently screen titles/abstracts and full-texts against eligibility criteria, extract the data, and assess the overall quality of evidence. Both observational and RCT studies will be eligible for inclusion if they report offspring mental health resilience/outcome and depressive symptoms or depressive disorder in at least one of the parents/caregivers. Risk of bias will be assessed using The Joanna Briggs Institute (JBI) critical appraisal checklists and The Revised Cochrane risk of bias tool for randomised trials (RoB 2). It is expected that studies will be heterogeneous; therefore, meta-analysis will not be attempted. Studies will be systematically retrieved and collated using numerical, graphical, tabular, and narrative summaries and grouped by their design, scope, or overall quality. Further sub-group analyses will be performed to examine sex-, developmental stage-, and outcome-specific protective factors. The proposed systematic review will be the first to summarise and critically assess quality and strength of evidence of protective factors associated with mental health resilience in offspring of depressed parents. Directions and effect sizes of the protective factors will be discussed as well as differences between the studies, their limitations, and research gaps and future directions. Strengths and limitations of the proposed systematic review will be also discussed. The proposed systematic review findings are expected to help better understand mental health resilience and identify targets for evidence-based prevention and intervention strategies for those in need. A previous version of this systematic review protocol has been registered in the International Prospective Register of Systematic Reviews (PROSPERO) database ( www.crd.york.ac.uk/PROSPERO , CRD42021229955).

Sections du résumé

BACKGROUND
Parental depression is associated with a range of mental health conditions and other difficulties in the offspring. Nevertheless, some offspring exposed to parental depression do not develop mental health problems, indicating the presence of protective factors that may buffer parental depression-related risk effects. However, evidence of protective factors that might explain good sustained mental health in offspring of depressed parents is limited and systematic synthesis of these factors is still needed. Therefore, as far as we are aware, this will be the first systematic review that will identify parent, family, child, social, and lifestyle factors associated with mental health resilience in offspring of depressed parents, examine evidence for sex-, developmental stage-, and outcome-specific factors and define mental health resilience in the parental depression context.
METHODS
This protocol has been developed according to the PRISMA-P guidelines. Electronic searches will be performed for articles published up to 2022 in PsycINFO, Embase, MEDLINE, Web of Science Core Collection, and Cochrane Library. Two reviewers will independently screen titles/abstracts and full-texts against eligibility criteria, extract the data, and assess the overall quality of evidence. Both observational and RCT studies will be eligible for inclusion if they report offspring mental health resilience/outcome and depressive symptoms or depressive disorder in at least one of the parents/caregivers. Risk of bias will be assessed using The Joanna Briggs Institute (JBI) critical appraisal checklists and The Revised Cochrane risk of bias tool for randomised trials (RoB 2). It is expected that studies will be heterogeneous; therefore, meta-analysis will not be attempted. Studies will be systematically retrieved and collated using numerical, graphical, tabular, and narrative summaries and grouped by their design, scope, or overall quality. Further sub-group analyses will be performed to examine sex-, developmental stage-, and outcome-specific protective factors.
DISCUSSION
The proposed systematic review will be the first to summarise and critically assess quality and strength of evidence of protective factors associated with mental health resilience in offspring of depressed parents. Directions and effect sizes of the protective factors will be discussed as well as differences between the studies, their limitations, and research gaps and future directions. Strengths and limitations of the proposed systematic review will be also discussed. The proposed systematic review findings are expected to help better understand mental health resilience and identify targets for evidence-based prevention and intervention strategies for those in need.
SYSTEMATIC REVIEW REGISTRATION
A previous version of this systematic review protocol has been registered in the International Prospective Register of Systematic Reviews (PROSPERO) database ( www.crd.york.ac.uk/PROSPERO , CRD42021229955).

Identifiants

pubmed: 36064439
doi: 10.1186/s13643-022-02056-6
pii: 10.1186/s13643-022-02056-6
pmc: PMC9446554
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

190

Subventions

Organisme : Medical Research Council
ID : MR/L010305/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 209138/Z/ 17/Z
Pays : United Kingdom

Informations de copyright

© 2022. The Author(s).

Références

Int J Evid Based Healthc. 2015 Sep;13(3):163-9
pubmed: 26262566
Am J Psychiatry. 2008 Sep;165(9):1148-54
pubmed: 18558644
Dev Cogn Neurosci. 2020 Oct;45:100835
pubmed: 32823179
World Psychiatry. 2014 Jun;13(2):153-60
pubmed: 24890068
Child Psychiatry Hum Dev. 2018 Oct;49(5):779-785
pubmed: 29468357
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
Am J Psychiatry. 2016 Oct 1;173(10):1024-1032
pubmed: 27113122
Mol Psychiatry. 2005 Sep;10(9):842-50
pubmed: 15838533
J Child Psychol Psychiatry. 2002 Jan;43(1):65-79
pubmed: 11848337
J Affect Disord. 2012 Jan;136(1-2):44-53
pubmed: 21962850
BMJ. 2009 Jul 21;339:b2535
pubmed: 19622551
Syst Rev. 2016 Dec 5;5(1):210
pubmed: 27919275
J Am Acad Child Adolesc Psychiatry. 1995 Sep;34(9):1221-9
pubmed: 7559318
Ann N Y Acad Sci. 2006 Dec;1094:1-12
pubmed: 17347337
Psychol Bull. 1994 Jul;116(1):29-45
pubmed: 8078972
Clin Psychol Rev. 2004 Jul;24(3):339-60
pubmed: 15245835
Psychol Bull. 1990 Jul;108(1):50-76
pubmed: 2200073
Clin Psychol Rev. 2008 Feb;28(2):179-98
pubmed: 17573169
J Child Psychol Psychiatry. 2013 Apr;54(4):474-87
pubmed: 23017036
Psychol Med. 1982 Nov;12(4):753-64
pubmed: 7156249
Dev Psychopathol. 2006 Spring;18(2):489-516
pubmed: 16600065
Lancet. 2012 Mar 17;379(9820):1056-67
pubmed: 22305766
Annu Rev Clin Psychol. 2013;9:327-54
pubmed: 23537487
J Adv Nurs. 2016 May;72(5):980-1000
pubmed: 26748456
J Am Acad Child Adolesc Psychiatry. 1998 Nov;37(11):1134-41
pubmed: 9808924
PLoS Med. 2019 Feb 21;16(2):e1002742
pubmed: 30789892
J Child Psychol Psychiatry. 2014;55(2):112-20
pubmed: 23808575
J Adolesc. 2018 Jun;65:207-218
pubmed: 29635170
Psychol Med. 1984 Nov;14(4):853-80
pubmed: 6545419
Lancet Psychiatry. 2016 Jan;3(1):49-57
pubmed: 26654748
Fam Soc. 2013;94(2):114-120
pubmed: 24860247
Soc Sci Med. 2006 May;62(10):2540-50
pubmed: 16316714
Neurosci Biobehav Rev. 2016 Oct;69:313-32
pubmed: 27395342
Lancet Public Health. 2019 Jun;4(6):e291-e300
pubmed: 31155222
Clin Psychol Rev. 2000 Mar;20(2):173-89
pubmed: 10721496
Am J Psychiatry. 2006 Jun;163(6):1001-8
pubmed: 16741200
JAMA Psychiatry. 2016 Mar;73(3):197-8
pubmed: 26841851

Auteurs

Eglė Padaigaitė (E)

Wolfson Centre for Young People's Mental Health, Section of Child and Adolescent Psychiatry, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Hadyn Ellis Building, Maindy Road, Cardiff, CF24 4HQ, UK. padaigaitee@cardiff.ac.uk.

Jessica Mayumi Maruyama (JM)

Departamento de Medicina Preventiva, Faculdade de Medicina FMUSP, Universidade de São Paulo, São Paulo, Brazil.

Gemma Hammerton (G)

Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, UK.

Frances Rice (F)

Wolfson Centre for Young People's Mental Health, Section of Child and Adolescent Psychiatry, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Hadyn Ellis Building, Maindy Road, Cardiff, CF24 4HQ, UK.

Stephan Collishaw (S)

Wolfson Centre for Young People's Mental Health, Section of Child and Adolescent Psychiatry, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Hadyn Ellis Building, Maindy Road, Cardiff, CF24 4HQ, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH